Funding for this research was provided by:
Sanming Project of Medicine in Shenzhen (SZSM201812005)
Shenzhen Key Medical Discipline Construction Fund (No.SZXK033)
Shenzhen Fund for Guangdong Provincial High Level Clinical Key Specialties (No.SZGSP012)
Received: 7 September 2021
Accepted: 19 December 2021
First Online: 15 February 2022
Change Date: 7 March 2022
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1186/s42494-022-00081-5
: This study was approved by the Medical Ethics Committee of Shenzhen Children’s Hospital, with a Clinical trial registration No. of ChiCTR-IIR-16008342. Informed consent was obtained from all patients in this study.
: Not applicable.
: Author JQ is the editorial board member for Acta Epileptologica. Author JQ was not involved in the journal’s review of, or decisions related to this manuscript. JX L is a consultant of Shenzhen Zeneca Biotechnology Co., LTD. Shenzhen, China.